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A B S T R A C T
The PowerPlex1 ESI 16 Fast, ESI 17 Fast, ESX 16 Fast, and ESX 17 Fast Systems represent faster cycling
versions (50 min or less) of the PowerPlex1 ESI and ESX Systems released by Promega in 2009 to
accommodate the ENFSI and EDNAP groups’ call for new STR multiplexes for Europe. In addition to
ampliﬁcation of puriﬁed DNA samples, these new faster cycling systems allow for direct ampliﬁcation
from single-source blood and buccal samples deposited on FTA1 and nonFTA paper as well as from
SwabSolutionTM extracts of buccal swabs without the need for puriﬁcation and quantitation. There are
no changes to the autosomal primer pair sequences in the PowerPlex1 ESI Fast and ESX Fast Systems
compared to the original multiplexes, and full concordance at all autosomal loci and amelogenin was
observed with data generated previously with the original PowerPlex1 ESI and ESX Systems. This paper
describes the developmental validation study performed on these new fast systems following guidelines
issued by the Scientiﬁc Working Group on DNA Analysis Methods (SWGDAM) and those of the DNA
Advisory Board (DAB). Validation data demonstrate that these systems are sensitive for detecting low
levels of DNA while also being capable of generating robust proﬁles from the high amount of input DNA
present in direct-ampliﬁcation samples. These systems are also tolerant to both high concentrations of
PCR inhibitors as well as to slight variations in the ﬁnal concentration of master mix and primer pair
present in the ampliﬁcation reaction that might be encountered due to pipetting error. The results of this
validation study demonstrate that these systems may be used on multiple thermal cyclers and capillary
electrophoresis platforms.
 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / fs ig1. Introduction
The PowerPlex1 ESI and ESX Systems were launched in 2009 to
accommodate the requirements for next-generation STR genotyp-
ing systems for Europe [1–3]. The PowerPlex1 ESI conﬁguration
was designed with six of the seven ESS loci (all but D21S11) along
with D16S539 and D19S433 as smaller amplicons (<250 bp), while
the ﬁve new loci were left as larger amplicons [4,5]. The
PowerPlex1 ESX conﬁguration was designed with the ﬁve new
loci as smaller amplicons [6]. Both multiplex conﬁgurations were* Corresponding author. Tel.: +1 608 274 4330x1902; fax: +1 608 277 2699.
E-mail address: bob.mclaren@promega.com (R.S. McLaren).
http://dx.doi.org/10.1016/j.fsigen.2014.08.004
1872-4973/ 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access 
nd/3.0/).designed with and without the SE33 locus as 17 and 16 plexes,
respectively [4–6].
Direct ampliﬁcation of samples (e.g., blood or buccal cells on a
solid support such as FTA1 (GE Healthcare/Whatman, Maidstone,
UK) or nonFTA cards or buccal swabs) has become popular in
recent years because it eliminates the need to purify DNA samples,
thereby saving time and the added expense of the DNA puriﬁcation
reagents. This increased demand has been met by the availability
of several direct ampliﬁcation compatible STR systems [7–9],
although mostly these systems are intended solely for direct
ampliﬁcation and not for ampliﬁcation of DNA puriﬁed from
casework samples, thus requiring that labs running single source
and casework samples need to validate two kits for each purpose.
The PowerPlex1 ESI and ESX Systems were not initially designed to
be compatible with direct ampliﬁcation and the cycling time wasarticle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
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newer direct ampliﬁcation systems may be cycled in 90 min or
less. For these reasons these four multiplexes were upgraded to
allow both direct ampliﬁcation and ampliﬁcation from puriﬁed
DNA samples with an overall cycling time of less than 1 h for both
sample types.
This paper presents developmental validation work performed
on these four STR multiplex systems. Validation tests were
designed to comply with guidelines issued by the Scientiﬁc
Working Group on DNA Analysis Methods (SWGDAM) [10] and
those of the FBI Quality Assurance Standards for Forensic DNA
Testing Laboratories [11].
2. Materials and methods
2.1. Human DNA samples
Unless otherwise stated, puriﬁed single source human DNA
samples used in this study were organically extracted from blood
and quantitated by absorbance at 260 nm on a NanoDrop1 ND-
1000 Spectrophotometer (Nano-Drop Technologies, Inc., Wilming-
ton, DE).
Single source direct ampliﬁcation samples were collected from
three individuals and comprised blood spotted onto FTA1 cards
(GE Healthcare/Whatman, Maidstone, UK), buccal cells transferred
to FTA1 cards, buccal cells collected on Bode Buccal DNA
CollectorsTM (Bode Technology, Lorton, VA), blood spotted onto
ProteinSaverTM 9031 (GE Healthcare/Whatman, Maidstone, UK),
and buccal cells collected on OmniSwabsTM (GE Healthcare/
Whatman, Maidstone, UK).
Standard Reference Materials 2391c, PCR Based DNA Proﬁling
Standard, components A–C (NIST, Gaithersburg, MD) were also
used for the accuracy and reproducibility studies.
2.2. Master mix and primer set optimization
The PowerPlex1 ESI/ESX Fast 5 Master Mix was used for the
PowerPlex1 ESI 16 Fast, ESI 17 Fast, ESX 16 Fast, and ESX 17 Fast
Systems and includes a proprietary hot-start thermostable DNA
polymerase, a buffering system, salts, magnesium chloride, carrier
protein, and dNTPs. The autosomal primer pair sequences are the
same as those used in the original PowerPlex1 ESI and ESX Systems
[4–6]. The sequences of the amelogenin primer pair are the same
except for the addition of three bases to the 5’ end of the unlabeled
primer which improves adenylation under the faster cycling
conditions and the removal of one base from the 5’ end of the
labelled primer which prevents formation of a blob artefact in the
60–70 base region of the blue dye channel. The SE33 primer pair
used in the PowerPlex1 ESI 17 Fast is the same as that used in the
PowerPlex1 ESI 17 Pro System [5].
The blue, green, yellow and red dye channels contain the STR
amplicons and are labelled with ﬂuorescein, JOE, TMR-ET, and
CXR-ET respectively. The orange dye channel is reserved for the
CC5-labelled Internal Lane Standard 500 Pro (CC5 ILS 500 Pro) size
standard.
2.3. Ampliﬁcation
Unless otherwise speciﬁed, ampliﬁcation reactions were
performed in triplicate. Each 25 mL ampliﬁcation reaction con-
tained 5 mL of PowerPlex1 ESI/ESX Fast 5 Master Mix and 2.5 mL
of the respective 10 Primer Pair Mix, with 17.5 mL available for
puriﬁed DNA sample and ampliﬁcation grade water. Direct
ampliﬁcation reactions were set up in the same way except that
5 mL of 5 AmpSolutionTM Reagent and 12.5 mL of ampliﬁcation
grade water (10.5 mL if performing an ampliﬁcation with 2 mL ofSwabSolutionTM extract) were used to bring the volume to 25 mL.
AmpSolutionTM Reagent protects the ampliﬁcation reaction
against chemicals in the FTA1 cards, SwabSolutionTM and
PunchSolutionTM Reagents that would otherwise inhibit the PCR.
The following direct ampliﬁcation sample types were used from
three donors each.
1. One 1.2 mm blood FTA1 punch
2. One 1.2 mm buccal FTA1 punch
3. Two 1.2 mm buccal FTA1 punches
4. One 1.2 mm blood on ProteinSaverTM 9031 punch (pre-treated
with PunchSolutionTM Reagent [12])
5. One 1.2 mm punch from Bode Buccal DNA CollectorsTM (pre-
treated with PunchSolutionTM Reagent [12])
6. SwabSolutionTM extract of OmniSwabTM (generated as de-
scribed in the SwabSolutionTM Kit Technical Manual [13])
Unless speciﬁed otherwise, thermal cycling was performed on
the GeneAmp1 PCR System 9700 thermal cycler with a silver or
gold-plated silver sample block (Life Technologies, Foster City, CA)
using the cycling parameters described in the technical manuals
[14–17]. These consisted of an initial activation of the thermosta-
ble DNA polymerase at 96 8C for 1 minute, followed by 30 cycles
(26 cycles for direct ampliﬁcation) of dentauration at 96 8C for 5 s,
annealing at 60 8C for 35 s and extension at 72 8C for 5 s. This was
followed by a ﬁnal extension at 60 8C for 2 min and a ramp down to
a 4 8C soak. Max ramp mode was used on the GeneAmp1 PCR
System 9700 thermal cycler. The same cycling protocol was
followed for experiments conducted on the 96-well (0.2 mL)
Veriti1 thermal cycler (Life Technologies, Foster City, CA) and the
GeneAmp1 PCR System 2720 thermal cycler (Life Technologies,
Foster City, CA). Ramp rate was left at ‘‘100%’’ on the 96-well
(0.2 mL) Veriti1 Thermal Cycler.
2.4. Capillary electrophoresis on Applied Biosystems 3130 and 3500
Series Genetic Analyzers
Ampliﬁed samples and allelic ladder were processed according
to the technical manuals [14–17]. One microliter of ampliﬁcation
product or allelic ladder was combined with 10 mL Hi-DiTM
formamide and 2 mL of CC5-labelled Internal Lane Standard 500
Pro (CC5 ILS 500 Pro). Samples were heated to 95 8C for 3 min prior
to quick chilling in a crushed wet-ice bath for at least 3 min
Samples were injected at 3 kV for 5 s on an Applied Biosystems
3130 or 3130xl Genetic Analyzer and at 1.2 kV for 24 seconds on
the Applied Biosystems 3500xL Genetic Analyzer. Data generated
on the Applied Biosystems 3130 or 3130xl Genetic Analyzer were
analyzed using GeneMapper1 ID 3.2.1 software (Life Technologies,
Foster City, CA) and a 50 RFU detection threshold whereas data
generated on the Applied Biosystems 3500xL Genetic Analyzer
were analyzed using GeneMapper1 ID-X software (Life Technolo-
gies, Foster City, CA) and a 175 RFU detection threshold.
2.5. Capillary electrophoresis on ABI PRISM1 310 Genetic Analyzer
Ampliﬁed samples and allelic ladder from the PowerPlex1 ESX
17 Fast System were processed for electrophoresis on the ABI
PRISM1 310 Genetic Analyzer with POP-4TM polymer as per
instructions in the PowerPlex1 ESX 17 Fast System Technical
Manual [17]. Ampliﬁed samples and allelic ladder from the
PowerPlex1 ESI 17 Fast System were processed for electrophoresis
on the ABI PRISM1 310 Genetic Analyzer with POP-6TM polymer as
per instructions in the PowerPlex1 ESI 17 Fast System Technical
Manual [15]. POP-6TM polymer provided better resolution than
POP-4TM polymer of larger alleles that are 1 base apart, such as is
the case with D2S441, D12S391, and D1S1656 in the PowerPlex1
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ladder was combined with 23 mL Hi-DiTM formamide and 2 mL of
CC5 ILS 500 Pro. Samples were heat denatured as described above.
Injection was performed at 15 kV for 3 s. Data were analyzed using
GeneMapper1 ID 3.2.1 software (Life Technologies, Foster City, CA)
and a 50 RFU detection threshold.
2.6. Magnesium and EDTA titrations
To provide information on the effect of increased magnesium
chloride or the effects of magnesium chelation on the results,
titrations of increasing magnesium chloride (MgCl2) concentration
(0.25 mM, 0.5 mM and 1 mM) or increasing EDTA concentration
(0.1 mM, 0.25 mM, 0.5 mM, and 1.0 mM) were carried out with all
four systems.
2.7. Master mix and primer pair mix titrations
To evaluate the effect of pipetting errors on performance of the
PowerPlex1 ESI Fast and ESX Fast Systems, ampliﬁcation reactions
were performed with ﬁnal concentrations of either the Master Mix
or Primer Pair Mix of 0.8, 0.9, 1.0 (recommended), 1.1, and
1.2.
2.8. Cycle number
Cycle number was examined with both puriﬁed DNA and all
direct ampliﬁcation samples. For puriﬁed DNA samples, ampliﬁ-
cation reactions were performed at 28, 30 (recommended), and 32
cycles of PCR. For direct ampliﬁcation samples, ampliﬁcation
reactions were performed at 25, 26, and 27 cycles.
2.9. Annealing temperature
The effect of annealing temperature was examined with both
puriﬁed DNA and blood and buccal samples on 1.2 mm FTA1
punches. Ampliﬁcation reactions were performed at annealing
temperatures of 56 8C, 58 8C, 60 8C (recommended), 62 8C and
64 8C.
2.10. Reaction volume
Puriﬁed DNA and direct ampliﬁcation samples (blood on FTA1
cards, blood on ProteinSaverTM 9031, and buccal cells collected on
OmniSwabsTM) were ampliﬁed at full (25 mL) and half-volume
(12.5 mL) reactions. For puriﬁed DNA samples, ampliﬁcation
reactions were performed with 500 pg and 50 pg 2800M Control
DNA (constant mass) as well as no-template. Reactions were also
performed with 20 pg/mL and 2 pg/mL 2800M Control DNA
(constant concentration) in both reaction volumes. For direct
ampliﬁcation samples, 25 mL and 12.5 mL reactions were per-
formed with 26, and 25 cycles, respectively (reduced cycle number
required for 12.5 mL ampliﬁcation reaction due to the two-fold
increase in DNA concentration that results from a two-fold
reduction in volume). A single 1.2 mm punch was used for both
reaction volumes. For SwabSolutionTM extract, 2 mL was used for
both reaction volumes.
2.11. Sensitivity
Two male DNA samples (2800M and QC2), were ampliﬁed at
the following template masses per 25 mL ampliﬁcation reaction:
2000 pg, 1000 pg, 500 pg, 250 pg, 125 pg, 62.5 pg, 31.25 pg, 15.6 pg
and 7.8 pg of DNA. Percent full proﬁle and peak height ratios (PHR)
for pairs of alleles at heterozygous loci (lowest peak height/largest
peak height) were calculated at all template levels. At low templateconcentrations, where one or both allele(s) had dropped below the
50 RFU analysis threshold, a value of zero was assigned to the
allele(s), resulting in a PHR of zero.
2.12. Inhibitor studies
Hematin (Sigma–Aldrich, cat.# H3281) was dissolved in 1 N
NaOH to a stock concentration of 2 mM and both humic acid
(Fluka, cat.# 53680) and tannic acid (Sigma–Aldrich, cat.# 403040)
were resuspended in NanoPure1water to a stock concentration of
5 mg/mL. Calcium chloride was used at a stock of 1 M. Ampliﬁca-
tion reactions contained hematin (100 mM, 200 mM, 400 mM or
800 mM) or humic acid (50 ng/mL, 100 ng/mL, 150 ng/mL or
200 ng/mL) or tannic acid (100 ng/mL, 200 ng/mL, 300 ng/mL or
400 ng/mL) or calcium chloride (0.5 mM, 1 mM, 1.5 mM, or 2 mM).
2.13. Mixture studies
Two mixture sets were evaluated (one male:female mixture
and one male:male mixture) at mixture ratios of 0:1, 1:19, 1:9, 1:4,
1:2, 1:1, 2:1, 4:1, 9:1, 19:1 and 1:0. The total mass of DNA present
at each mixture ratio was 500 pg (i.e., 475 pg and 25 pg of the
major and minor contributor, respectively, at a 19:1 ratio).
Duplicate reactions were performed at each ratio. The percentage
of unique minor contributor alleles (deﬁned as an allele not shared
with the major contributor, or if present in a stutter position of a
major allele; its peak height exceeding the stutter threshold at that
locus) detected at each ratio was determined.
2.14. Degraded samples
Twenty ﬁve microliters of 2800M control DNA (10 ng/mL) was
exposed to either 100 mJ, 200 mJ or 300 mJ of UV-C (254 nm) light
by placing the DNA samples on top of Paraﬁlm sitting on crushed
ice in a UV Stratalinker 1800.
2.15. Reproducibility, accuracy and precision
Components A, B, and C of the Standard Reference Materials
2391c, PCR Based DNA Proﬁling Standard and 2800M Control DNA
were genotyped by Promega (all four systems), Key Forensics
(PowerPlex1 ESI Fast) and NBI (PowerPlex1 ESX Fast) to
demonstrate inter-laboratory reproducibility. Direct-ampliﬁcation
samples described above were also sent to Key Forensics and NBI
for direct ampliﬁcation.
Sizing precision was determined from multiple injections of
allelic ladders from the PowerPlex1 ESI 17 Fast and ESX 17 Fast
Systems run with POP-4TM polymer on the Applied Biosystems
3130xl and 3500xL Genetic Analyzer as well as the ABI PRISM1 310
Genetic Analyzer (using POP-4TM polymer for the PowerPlex1 ESX
17 Fast System and POP-6TM polymer for the PowerPlex1 ESI 17
Fast System). Accuracy was determined by comparing the sizes of
the alleles in components A–C of the Standard Reference Materials
2391c, PCR Based DNA Proﬁling Standard and 2800M to the sizes of
the corresponding alleles in the allelic ladder.
2.16. Species speciﬁcity
Speciﬁcity towards human DNA was demonstrated by perform-
ing PowerPlex1 ESI 17 Fast and ESX 17 Fast reactions with either
2 ng of animal DNA or 10 ng of microbial DNA per 25 mL reaction.
Animal DNA samples tested were cow, dog, cat, rabbit, deer,
mouse, and chicken. Microbial DNA isolates were Acinetobacter
lwofﬁ (#17925D), Streptococcus mutans (#700610D-5), Lactobacillus
acidophilus (#4357D-5), Staphylococcus epidermidis (#35984D-5),
Enterococcus faecalis (#700802D-5), Haemophilus inﬂuenza
R.S. McLaren et al. / Forensic Science International: Genetics 13 (2014) 195–205198(#51907D), Pseudomonas aeruginosa (#17933D), Bacillus cereus
(#14579D-5), Candida albicans (#10231D-5), Saccharomyces cerevi-
siae (#204508D), Fusobacterium nucleatum (#25586D-5), Micro-
coccus luteus (#53598D), Streptococcus salivarius (#9759D-5), and
Streptococcus mitis (#49456D-5) (ATCC, Manassas, VA). Primate
DNA samples were also ampliﬁed at 1 ng per 25 mL reaction.
Primate DNA samples tested were macaque, orangutan, gorilla,
and chimpanzee.
2.17. Specimens and mock casework
2.17.1. Key Forensics’ mock casework samples: PowerPlex1 ESI Fast
Systems
Twenty mock casework samples, which had previously been
processed and genotyped, provided a range of sample types and
DNA concentrations (Supplemental Table 1). The DNA was
extracted and puriﬁed using the QIAamp DNA Mini Kit (Qiagen
N.V., Venlo, Netherlands) [18], and Microcon DNA Fast Flow
Centrifugal Filter Units (Merck Millipore). For the seminal samples,
a standard differential extraction method utilizing the Animal
Tissue Lysis (ATL) Buffer from the QIAamp DNA Mini Kit for washes
of the sperm pellet. The extracts were quantiﬁed in duplicate using
the Plexor1 HY System [19], and an average concentration
calculated. The DNA extracts were ampliﬁed using the PowerPlex1
ESI 16 Fast and ESI 17 Fast Systems using a 0.5 ng DNA template in
a 25 mL reaction.
The results were compared to those obtained using the
current procedure in use at Key Forensics (1 ng DNA template
using AmpFlSTR1 SGM Plus1 PCR Ampliﬁcation Kit) [20]. This is
a 12.5 mL ampliﬁcation reaction performed for 28 cycles on a 96-
well (0.2 mL) Veriti1 thermal cycler. One microliter of ampliﬁ-
cation product or allelic ladder was combined with 8.875 mL Hi-
DiTM formamide and 0.125 mL of GeneScanTM 500 ROXTM Size
Standard (Life Technologies, Foster City, CA). They were run on an
Applied Biosystems 3500xL Genetic Analyzer (injected at 1.2 kV
for 20 s).
2.17.2. NBI’s mock casework samples: PowerPlex1 ESX Fast Systems
Forty-four previously genotyped mock casework samples
(Supplemental Table 2) were ampliﬁed using the PowerPlex1
ESX 16 Fast and ESX 17 Fast Systems. Samples contained both
single-source DNA and mixtures, with various amount of DNA.
DNA was extracted either on a Tecan Freedom EVO platform with
ChargeSwitch1 Forensic DNA Puriﬁcation kit (Invitrogen & Life
Technologies, Foster City, CA) [21], or with a Maxwell116
instrument using Casework Extraction Kit and DNA IQTM Casework
Pro Kit (Promega, Madison, WI) [22]. The extracts were quantiﬁed
using the Investigator1 Quantiplex Kit (Qiagen N.V., Venlo,
Netherlands) [23]. Ampliﬁcation reactions were performed as
described in Section 2.3, targeting 0.5 ng DNA per 25 mL reaction
(or the maximum sample volume possible if concentration of DNA
sample was too low to achieve 0.5 ng) except that cycling was
performed on a Mastercycler Nexus PCR Cycler with aluminium
block (Eppendorf, Hamburg, Germany).
The genotypes obtained were compared to those previously
generated using the Investigator1 ESSplex Plus Kit [24]. For
ChargeSwitch1 puriﬁed samples, a standard 25 mL Investigator1
ESSplex Plus reaction volume with maximum of 15 mL of
template DNA was used. Maxwell-extracted samples were
ampliﬁed using a reduced 16.7 mL reaction volume with
maximum of 10 mL of template DNA. Investigator1 ESSplex Plus
ampliﬁcation reactions were performed with a standard 30 cycle
protocol on a Mastercycler Nexus PCR Cycler with aluminium
block except for an additional 3 min ﬁnal extension step at 68 8C.
One microliter of ampliﬁcation product or allelic ladder wascombined with 11.5 mL Hi-DiTM formamide and 0.5 mL of BTO
Size Standard (Qiagen N.V., Venlo, Netherlands). Electrophoresis
was done on an Applied Biosystems 3500xL Genetic Analyzer
(injected at 3.0 kV for 8 s).
2.18. Concordance and stutter
The PowerPlex1 ESI 17 Fast and ESX 17 Fast Systems were used
to genotype DNA from anonymous liquid blood samples from 656
unrelated individuals and 720 father and son pairs that were
previously typed with the PowerPlex1 ESX 17, ESI 17, and ESI 17
Pro Systems [5,25] along with six samples from the Standard
Reference Materials 2391c, PCR Based DNA Proﬁling Standard and
10 samples from the Standard Reference Materials 2391b, PCR
Based DNA Proﬁling Standard. Ampliﬁcation products were
analyzed on an Applied Biosystems 3130xl Genetic Analyzer. All
genotyping was performed with GeneMapper ID-X v1.4 software.
Data tables were exported into Excel (Microsoft, Redmond, WA)
and compared to data generated previously with the PowerPlex1
ESX 17 and ESI17 Systems [25], and the Powerplex1 ESI 17 Pro
System [5]. N  4 and N + 4 (N  3 and N + 3 for D22S1045) stutter
percentages were calculated for all loci based on peak height from
the data generated from unrelated individuals with the STR_Stut-
terFreq Excel based software developed at NIST [26]. To ensure that
data was not used from main allele peaks that were saturating, or
where the main allele peak was too low and potentially in the
stochastic range, stutter percentages were only calculated where
the major allele was between 200 and 4000 RFU. In addition, to
exclude contributions from N + 4 stutter that could artiﬁcially raise
the height of the N  4 stutter peak, N  4 stutter was not
calculated for alleles at heterozygous loci where the larger allele
was two repeats away from the smaller allele at that locus. N  2
stutter was calculated for D1S1656 and SE33.
3. Results
3.1. Reaction conditions — magnesium and EDTA titration
Full proﬁles were obtained in the presence of 0.5 mM EDTA for
both the PowerPlex1 ESI Fast and ESX Fast conﬁgurations
(Supplemental Fig. 1). Signal decreased at all loci with increasing
EDTA concentration for both conﬁgurations, except at vWA.
Increased magnesium chloride either showed no effect or an
increase in signal at a given locus (data not shown).
3.2. Reaction conditions — master mix and primer pair mix titration
Changes of 10% in the ﬁnal concentration of master mix and
primer pair mix were tolerated by both the PowerPlex1 ESI Fast and
ESX Fast Systems. An increase of either master mix or primer pair
mix to a ﬁnal concentration of 1.2 had minimal effect on these
systems. However, decreasing the concentration of master mix or
primer pair mix to 0.8 adversely affected the signal and balance,
particularly for the PowerPlex1 ESI Fast Systems (Fig. 1 and
Supplemental Fig. 2).
3.3. Reaction conditions — effect of AmpSolutionTM Reagent
Direct ampliﬁcation is facilitated by the inclusion of AmpSo-
lutionTM Reagent in the reaction. Inclusion of AmpSolutionTM
Reagent in the ampliﬁcation reaction has no effect on the signal or
balance of the proﬁle obtained whether 500 pg of DNA is ampliﬁed
for 30 cycles or 10 ng for 26 cycles (Supplemental Figs. 3 and 4). No
additional ampliﬁcation artefacts were seen in the presence of
AmpSolutionTM Reagent over those documented in the technical
manuals (data not shown) [14–17].
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Fig. 1. Locus-to-locus balance and signal in the PowerPlex1 ESI 17 Fast and ESX 17 Fast Systems as function of ﬁnal master mix and primer pair mix concentration. Mean peak
height was determined at each locus from triplicate ampliﬁcation reactions of 500 pg 2800M control DNA at 0.8, 0.9, 1.0, 1.1, and 1.2 ﬁnal concentration of master mix
(MM) and primer pair mix (PM). Loci are arranged in order (left to right) from smallest to largest amplicons in blue, green, yellow, and red dye channels. Ampliﬁcation
reactions were performed using a GeneAmp1 9700 thermal cycler and 1 mL of each sample was electrophoresed on a 3130 series instrument following a 3 kV, 5-s injection.
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3.4.1. Puriﬁed DNA
Increasing cycle number from 28 to 30 cycles resulted in the
anticipated increase in signal across all loci for the PowerPlex1 ESI
17 Fast and ESX Fast 17 Systems. At 32 cycles, the increase in signal
was not uniform across all loci, resulting in a locus-to-locus
imbalance (Supplemental Fig. 5). Similar results were obtained for
the two 16 plexes (data not shown). Increasing cycle number did
not result in the appearance of additional artefact peaks in the no-
template ampliﬁcations reactions (data not shown).
3.4.2. Direct ampliﬁcation
We looked at the effect of increasing cycle number from 25 to
27 cycles on blood FTA1 cards (Fig. 2) and buccal FTA1 cards
(Supplemental Fig. 6), blood on ProteinSaverTM 9031 cards
(Supplemental Fig. 7), Bode Buccal Collectors (Supplemental Fig.
8), and SwabSolutionTM extracts (Supplemental Fig. 9). Signaltended to increase with cycle number for all direct ampliﬁcation
samples. When using two 1.2 mm buccal FTA1 punches, full
proﬁles were obtained with all samples at all cycle numbers.
Dropout at one locus (in this case one allele at SE33 in one replicate
of donor 2) was seen at 25 cycles when using one 1.2 mm buccal
FTA1 punch (Supplemental Table 3, data not shown for 16 plexes),
but not with any of the other direct ampliﬁcation sample types at
any cycle number. The genotypes obtained for a given donor were
concordant with each other between cycle numbers and across
direct ampliﬁcation sample types tested.
3.5. Reaction conditions — annealing temperature
3.5.1. Puriﬁed DNA
Increasing the annealing temperature to 62 8C from the
recommended 60 8C resulted in a signiﬁcant reduction in signal
at amelogenin, D8S1179 and FGA with the PowerPlex1 ESI Fast
Systems (occasional drop-out at amelogenin and D8S1179 at
Fig. 2. Cycle number study with blood FTA1 card punches ampliﬁed with the PowerPlex1 ESI 17 Fast and ESX 17 Fast Systems. Ampliﬁcation of a single 1.2 mm punch was
performed per 25 mL reaction for 25, 26, or 27 cycles on a GeneAmp1 9700 thermal cycler and 1 mL of each sample was electrophoresed on a 3130 series instrument following
a 3 kV, 5-s injection. PowerPlex1 ESI 17 Fast Y axes: 8000 RFU, PowerPlex1 ESX 17 Fast Y axes: 10000 RFU.
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some replicates at D2S1338 and D19S433. Overall, 90–100% of
alleles were obtainable at 62 8C and 61–76% at 64 8C with the
PowerPlex1 ESI Fast Systems (Supplemental Fig. 10). For the
PowerPlex1 ESX Fast Systems, 94–100% of alleles were called at
62 8C and 42–58% at 64 8C (Supplemental Fig. 10). The main loci
affected by increasing annealing temperature were amelogenin,
D1S1656, D8S1179, D10S1248, D12S391, D16S539, D22S1045 and
SE33, all of these loci dropping out at 64 8C. Decreasing annealing
temperature did not have a signiﬁcant effect on peak height.
As annealing temperature decreased with the PowerPlex1 ESX
Fast Systems, the known artefact peak at 63–65 bases in yellow[16,17] gradually increased in intensity but never saturated. In the
PowerPlex1 ESI Fast Systems, there was no signiﬁcant increase in
intensity of any of the known artefact peaks [14,15], although at
56 8C a low intensity artefact peak was seen at 183–184 bases
within the vWA locus. This was not present at 58 8C or at the
recommended 60 8C annealing temperature.
3.5.2. Direct ampliﬁcation
Blood and buccal FTA1 card punches generated full proﬁles at
the recommended 60 8C annealing temperature with all four
systems. The effect of annealing temperature on loci with direct
ampliﬁcation samples correlates with that observed with puriﬁed
R.S. McLaren et al. / Forensic Science International: Genetics 13 (2014) 195–205 201DNA. Full proﬁles were obtained for both blood and buccal FTA1
card punches with all four fast systems at 60 8C, 58 8C and 56 8C.
There was no signiﬁcant increase in peak height of known artefacts
at 58 8C and 56 8C.
3.6. Reaction conditions — thermal cyclers
Peak height and balance with 500 pg DNA was comparable on
the GeneAmp1 PCR System 9700, and 96-well (0.2 mL) Veriti1Fig. 3. PowerPlex1 ESI 17 Fast and ESX 17 Fast Ampliﬁcation on the GeneAmp1 9700 an
3130 series instrument following a 3 kV, 5-s injection. Y-axes: 2500 RFU.thermal cyclers (Fig. 3 for 17 plexes; data not shown for 16 plexes)
with similar sensitivity at 50 pg (data not shown). On the
GeneAmp1 PCR System 2720 thermal cycler there was a drop in
signal at TH01 (63–69% of signal on 9700) and D2S1338 (50–55% of
signal on 9700) for both the PowerPlex1 ESI Fast and ESX Fast
Systems. This effect was overcome by raising the denaturation
temperature during cycling from 96 8C to 98 8C (Supplemental Fig.
11). No additional artefacts were observed in template and no-
template ampliﬁcation reactions performed on the GeneAmp1d Veriti1 thermal cyclers. One microliter of each sample was electrophoresed on a
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over those noted previously on the GeneAmp1 PCR System 9700
thermal cycler [14–17].
3.7. Reaction conditions — reaction volume
3.7.1. Puriﬁed DNA (constant mass and concentration)
At a constant mass of DNA the overall signal doubles as the
reaction volume is reduced from 25 mL to 12.5 mL. However, if the
concentration is kept constant, then the overall peak heights
remain consistent (See Supplemental Fig. 12 for both 17 plexes.
Data not shown for 16 plexes). No new artefacts were seen in the
reduced volume reactions, either in the presence or absence of
DNA template (data not shown).
3.7.2. Direct ampliﬁcation
For all four fast systems, full proﬁles were obtained from all
replicate ampliﬁcations from each of the three donors at both full
and half reactions with either a single 1.2 mm punch from a blood
stain on FTA1 or a blood stain on ProteinSaverTM 903 or 2 mL of a
SwabSolutionTM Extract (Supplemental Table 4).
3.8. Sensitivity
Full proﬁles were obtained with 2800M and QC2 DNA at 125 pg
DNA and 98–100% of alleles were called at 62.5 pg with all four
multiplexes on both the 3130 and 3500 series CE instruments0%
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Fig. 4. The average percentage of alleles called at each mass of either 2800M or QC2 DNA
standard deviation of the mean from triplicate ampliﬁcation reactions. Ampliﬁcation re
sample was electrophoresed on a 3130 series instrument following a 3 kV, 5-s injectio(Fig. 4 and Supplemental Fig. 13). On the 3130 series CE instrument
61–87% and 28–56% of alleles were called at 31 pg and 15.5 pg,
respectively whereas on the 3500 series these numbers were 86–
94% and 51–71%. As the mass of DNA ampliﬁed decreased, the peak
height ratio (PHR) at heterozygous loci became more variable with
some alleles dropping out at 62.5 pg and below, resulting in PHR
values of zero (Supplemental Fig. 14).
3.9. Effect of PCR inhibitors
Full proﬁles were obtained at 400 mM hematin, 100 ng/mL
humic acid, 200 ng/mL tannic acid and 0.5 mM calcium chloride.
Above these concentrations, dropout of alleles was observed, the
most signiﬁcant inhibition occurring with calcium chloride and the
least with humic acid (Supplemental Fig. 15). The performance in
the presence of PCR inhibitors is comparable to that seen with the
standard cycling systems [4,5].
3.10. Mixture studies
All of the unique minor contributor alleles were detected at the
1:1 and 2:1 ratios with both mixture sets with the PowerPlex1 ESI
Fast and ESX Fast Systems (Supplemental Fig. 16). At the 4:1 ratio,
94–100% of all unique minor contributor alleles were detected
with all four multiplexes with the values dropping below 100% due
to a minor contributor allele that fell in a stutter position being
ﬁltered out by the stutter ﬁlter for that locus. As the mixture ratio2.5pg 31 pg 15.5 pg 7.8 pg
moun t
ESI  16 Fast
ESI  17 Fast
ESX  16 Fast
ESX  17 Fast
2.5pg 31 pg 15.5 pg 7.8 pg
moun t
ESI  16   Fa st
ESI  17 Fast
ESX  16 Fast
ESX  17 Fast
 ampliﬁed with the PowerPlex1 ESI Fast and ESX Fast Systems. Error bars show the
actions were performed using a GeneAmp1 9700 thermal cycler and 1 mL of each
n.
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percentage of unique minor contributor alleles detected (Supple-
mental Fig. 16).
3.11. Degraded samples
Exposure to increasing UV-C energy results in a classic
degradation proﬁle with both PowerPlex1 ESI 17 Fast and ESX
17 Fast Systems (Supplemental Fig. 17). At 100 mJ of UV-C
exposure drop-out was seen at D10S1248 and D2S441 in Power-
Plex1 ESI 17 Fast and D18S51, D16S539, D2S1338, and FGA in
PowerPlex1 ESX 17 Fast (Supplemental Table 5). These loci
correspond to some of the largest loci in each multiplex.
3.12. Sizing precision and accuracy
For both multiplex conﬁgurations, the largest standard devia-
tion of the mean size obtained for each ladder allele on the Applied
Biosystems 3130 and 3500 series Genetic Analyzers did not exceed
0.11 bases and 0.10 bases, respectively whereas on the ABI PRISM1
310 Genetic Analyzer this value never exceeded 0.14 bases. The
sizes of all alleles obtained with components A, B, and C of the
Standard Reference Materials 2391c, PCR Based DNA Proﬁling
Standard and 2800M Control DNA with both multiplex conﬁg-
urations were within 0.5 bases of the size of the corresponding
allele in the allelic ladder.
3.13. Reproducibility
3.13.1. Puriﬁed DNA
Expected genotypes were obtained for components A–C of the
Standard Reference Materials 2391c, PCR Based DNA Proﬁling
Standard, and 2800M control DNA in ampliﬁcation reactions
performed at Promega (all four systems), Key Forensics (Power-
Plex1 ESI Fast Systems) and NBI (PowerPlex1 ESX Fast Systems).
3.13.2. Direct ampliﬁcation samples
The genotypes obtained for each donor were concordant in
replicate ampliﬁcation reactions across all three locations and
across all direct ampliﬁcation sample types.
3.14. Species speciﬁcity
Excluding the primate species, no peaks were detectable above
50 RFU in either PowerPlex1 ESI 17 Fast or ESX 17 Fast for any of
the domestic animal or microbial samples except for A. lwofﬁ
which showed a peak at 292–293 bases with a height of 94–
108 RFU in the green dye channel (D10S1248) of PowerPlex1 ESI
17 Fast and also at 89–90 bases with a height of 116–129 RFU in
the green dye channel (D10S1248) of PowerPlex1 ESX 17 Fast. In
both cases the peaks migrated on-ladder as an 11 allele. A. lwofﬁ is
part of the normal oropharynx and skin ﬂora of about 25% of
individuals [27] with a genome size of 3.48 Mb. At 10 ng DNA in an
ampliﬁcation reaction, this equates to 2.6 million genome copies
which suggests a low level cross hybridization to give a peak of the
height seen. Primates show the most ampliﬁcation peaks with
fewest being seen with macaque, followed by gorilla and
orangutan with a comparable number of peaks and the greatest
number with chimpanzee (Supplemental Fig. 18).
3.15. Case-type samples
3.15.1. PowerPlex1 ESI Fast Systems
The results from the 20 mock crime stain samples ampliﬁed
with the PowerPlex1 ESI Fast Systems were either the same or
better than the equivalent AmpFlSTR1 SGM Plus1 results in termsof number of alleles recovered (Supplemental Table 6). Full proﬁles
were concordant with the AmpFlSTR1 SGM Plus1 proﬁle of the
major donor.
3.15.2. PowerPlex1 ESX Fast Systems
In general the 44 mock crime stain samples ampliﬁed with the
PowerPlex1 ESX Fast Systems generated allele calls that were
concordant with those obtained with the Investigator1 ESSplex
Plus Kit with recovery of similar numbers of alleles (Supplemental
Table 7). However, a few samples had apparent discordant allele
calls. In the case of samples 13-031518R-01-1, 13-031880R-01-1,
and 13-031881R-01-1, the PowerPlex1 ESX Fast Systems called a
16.3 allele at D1S1656. This was labelled off-ladder with the
Investigator1 ESSplex Plus Kit due to the allele migrating just to
the right edge of the 16.3 allele bin position. In addition, in sample
13-031881R-01-1 there was an apparent discordance at D1S1656
with the Investigator1 ESSplex Plus Kit calling this as an OL, 17.3
whereas PowerPlex1 ESX 17 Fast genotyped this sample as 16.3,
18.3. This sample was a low level mixture (PowerPlex1 ESX 17 Fast
proﬁle showed three alleles at the SE33 locus) and gave a partial
proﬁle for the major contributor with Investigator1 ESSplex Plus
and a full proﬁle for the major contributor with PowerPlex1 ESX 17
Fast. However, ampliﬁcation of the major contributor to this
mixture with PowerPlex1 ESI 17 Fast and ESX 17 Fast (primer pairs
for D1S1656 being different between these two multiplexes) gave
a genotype of 16.3, 18.3 with both kits as well as with the
Investigator1 ESSplex Plus Kit (Supplemental Fig. 19). Thus, the
discordance seen with this casework sample appears to be due to
this being a low level mixture with the 17.3 allele possibly being
due to the second minor contributor in this mixed casework
sample. Unfortunately, there was no additional sample 13-
031881R-01-1 to repeat ampliﬁcation or any reference sample
for the potential minor contributor to allow a direct conﬁrmation
of the origin of the D1S1656 17.3 allele. The only other example of
an apparent true discordance due to an allele dropout occurred in
sample 13-011549R-02-1. This was a single source sample and was
called as a 16 homozygote in D10S1248 by the Investigator1
ESSplex Plus Kit and a 14, 16 heterozygote by both PowerPlex1 ESX
Fast Systems.
3.16. Concordance and stutter
Genotypes were obtained from 1392 samples for the PowerPlex1
ESI 17 Fast System and 1387 samples for the PowerPlex1ESX 17 Fast
System. There was no discordance between the fast cycling and
standard cycling chemistries. Thus, the genotype and allele
frequencies recently reported for loci present in the PowerPlex1
ESI Fast and ESX Fast Systems may be used with these systems [28].
Stutter percentages were calculated from the 656 unrelated
individuals used in the concordance study. Percentage stutter was
determined for products that were both one repeat unit smaller
(N  4/N  3) and larger (N + 4/N + 3) in length than the true allele
at all autosomal loci and for products that are two bases (N  2)
smaller than the true allele at D1S1656 and SE33. The plus one
repeat unit stutter is low for all tetranucleotide repeats, but higher
for the trinucleotide repeat D22S1045. The mean, standard
deviation of the mean (SD), and maximum stutter observed across
all alleles at each locus in both multiplex conﬁgurations are shown
in Tables 1 and 2. The mean plus three SD values in each table are
used as the recommended stutter ﬁlter in the GeneMapper1 ID
panel ﬁle and the GeneMapper1 ID-X stutter ﬁle.
4. Discussion
The PowerPlex1 ESI Fast and ESX Fast Systems allow for rapid
ampliﬁcation on a variety of thermal cyclers from both puriﬁed
Table 1
Stutter values for the PowerPlex1 ESI Fast System. Stutter values were calculated for one repeat below and one repeat above the main allele peak using data from the
concordance study. All loci are four base repeats except for D22S1045 (underlined) which is a three base repeat. For D1S1656 and SE33, N  2 stutter values were also
determined. Number of observations (n) made at each locus for each type of stutter is indicated. The stutter ﬁlter used in the GeneMapper1 ID panel ﬁle (minus one repeat
stutter only) and the GeneMapper1 ID-X stutter ﬁle (plus and minus one repeat as well as N  2 stutter) use the mean plus three times the standard deviation (SD) values
indicated in italics. Values for loci in the maximum observed stutter columns (Max) that are marked with an asterisk indicate that the maximum stutter observed was
elevated compared to rest of range in that data set with the value in parentheses indicating the next highest observed stutter value.
Locus Minus one repeat stutter (%) Plus one repeat stutter (%) N  2 stutter (%)
n Mean SD Mean + 3SD Max n Mean SD Mean + 3SD Max n Mean SD Mean + 3SD Max
D3S1358 461 8.7 1.4 12.9 14.1 318 0.9 0.4 2.1 2.9
D19S433 581 6.3 1.7 11.4 11.8 60 0.8 0.5 2.3 2.8
D2S1338 837 8.7 1.8 14.1 15.4 35 1.3 0.9 4.0 5.4
D22S1045 566 8.4 4 20.4 17.9 629 3.8 1.7 8.9 8.4
D16S539 468 5.7 1.7 10.8 10.9 440 1.3 0.6 3.1 4.6
D18S51 739 8.1 2.3 15.0 16.5 464 1.1 0.6 2.9 5.5
D1S1656 731 8.2 2.2 14.8 16.3 590 1.3 0.5 2.8 4.0 670 1.4 0.6 3.2 6.5
D10S1248 406 7.5 1.6 12.3 13.2 133 0.9 0.6 2.7 6.5* (2.4)
D2S441 581 4.7 1.8 10.1 9.2 375 0.9 0.4 2.1 2.9
TH01 526 2.1 0.8 4.5 5.2 115 0.9 0.4 2.1 2.4
vWA 492 7.2 2.5 14.7 12.9 149 1.2 1 4.2 9.1* (4.7)
D21S11 611 8 1.8 13.4 16.0 565 1.4 0.7 3.5 5.5
D12S391 700 8.7 2.9 17.4 22.9 123 1.1 0.7 3.2 3.4
D8S1179 511 6.8 1.6 11.6 12.0 363 0.9 0.6 2.7 6.2
FGA 667 6.7 1.7 11.8 11.6 359 0.9 0.5 2.4 4.2
SE33 970 7.5 2.4 14.7 29.3* (16.8) 401 1.1 0.6 2.9 5.0 644 2 0.8 4.4 4.9
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primer pairs incorporated in the original standard cycling systems
[4–6]. By using the same autosomal primer pairs (and only minor
changes to the 50 end of the amelogenin primers), concordance and
species speciﬁcity was maintained under the faster cycling
conditions.
Despite a 4-fold reduction in cycling time there is no signiﬁcant
reduction in performance in the presence of PCR inhibitors, overall
sensitivity, ability to detect minor contributors in two person
mixtures or in stutter when compared to the original standard
cycling systems [4,5,6,28]. The ability to perform direct ampliﬁca-
tion on a variety of single source reference sample types is
conferred by the incorporation of AmpSolutionTM Reagent into the
reaction with concordant genotypes obtained across diverse direct
ampliﬁcation sample types, both within and between labs. In
conjunction with the reproducible genotypes obtained withTable 2
Stutter values for the PowerPlex1 ESX Fast System. Stutter values were calculated for 
concordance study. All loci are four base repeats except for D22S1045 (underlined) w
determined. Number of observations (n) made at each locus for each type of stutter is in
stutter only) and the GeneMapper1 ID-X stutter ﬁle (plus and minus one repeat as well
indicated in italics. Values for loci in the maximum observed stutter columns (Max) th
elevated compared to rest of range in that data set with the value in parentheses indi
Locus Minus one repeat stutter (%) Plus one repeat 
n Mean SD Mean + 3SD Max n Mean 
D3S1358 466 8.9 1.6 13.7 19.3 398 1 
TH01 583 2 0.8 4.4 5.9 23 0.7 
D21S11 692 7.9 1.6 12.7 13.4 653 1.4 
D18S51 697 7.3 2.2 13.9 13.8 485 1.1 
D10S1248 439 8.6 1.7 13.7 14.5 145 0.9 
D1S1656 791 8.8 2.2 15.4 19.3* (15.9) 670 1.4 
D2S1338 831 8.1 1.8 13.5 17.1 175 1.5 
D16S539 493 6.3 2.3 13.2 14.1 397 1.4 
D22S1045 503 8.1 3.9 19.8 15.9 633 5.1 
vWA 493 7 2.7 15.1 12.4 155 1.1 
D8S1179 487 6.6 1.7 11.7 13.0 368 1.4 
FGA 590 6.9 2.2 13.5 15.6 354 1.2 
D2S441 657 5 1.7 10.1 18.2* (11.3) 512 1.3 
D12S391 744 9.3 3 18.3 18.7 203 1.3 
D19S433 559 6.4 1.7 11.5 12.8 83 1.1 
SE33 990 7.7 2.3 14.6 16.7 370 1.1 components A–C of the NIST SRM 2391c standard across the
laboratories participating in this study, these data conﬁrm that
these systems can be used to generate reliable and reproducible
genotypes from both puriﬁed DNA and direct samples.
In conclusion, the PowerPlex1 ESI Fast and ESX Fast Systems
represent a set of STR multiplexes that meet the locus
requirements of the European standard. The systems improve
over the original systems by reducing the cycling time to under
1 h and providing the ﬂexibility of use for a variety of direct
ampliﬁcation and puriﬁed DNA samples types in either full or
reduced reaction volumes on a variety of thermal cyclers,
generating ampliﬁcation products that may be detected on a
range of commonly used capillary electrophoresis platforms. The
studies conducted in this paper under SWGDAM guidelines
validate the suitability of these fast systems for use on forensic
casework and database samples.one repeat below and one repeat above the main allele peak using data from the
hich is a three base repeat. For D1S1656 and SE33, N  2 stutter values were also
dicated. The stutter ﬁlter used in the GeneMapper1 ID panel ﬁle (minus one repeat
 as N  2 stutter) use the mean plus three times the standard deviation (SD) values
at are marked with an asterisk indicate that the maximum stutter observed was
cating the next highest observed stutter value.
stutter (%) N  2 stutter (%)
SD Mean + 3SD Max n Mean SD Mean + 3SD Max
0.4 2.2 3.1
0.3 1.6 1.5
0.6 3.2 5.1
0.6 2.9 6.8* (4.3)
0.5 2.4 3.0
0.5 2.9 5.5 821 1.8 0.6 3.6 5.4
0.8 3.9 4.2
0.8 3.8 5.8
2 11.1 10.1
0.7 3.2 5.5
0.9 4.1 6.2
0.9 3.9 8.2* (5.9)
0.4 2.5 3.2
0.8 3.7 5.4
0.7 3.2 4.3
0.7 3.2 4.9 967 2.9 0.9 5.6 6.3
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